| EVALI | vaping product-associated lung illness |
| COPD | chronic obstructive pulmonary disease |
| PG | propylene glycol |
| VG | vegetable glycerin |
| BAL | bronchoalveolar lavage |
| THC | tetrahydrocannabinol |
| CBD | cannabidiol |
| PM | particulate matter |
| GRAS | generally recognized as safe |
| PEG | polyethylene glycol |
| MCT | medium chain triglycerides |
| nAChRs | nicotinic acetylcholine receptors |
| TSNAs | tobacco-specific nitrosamines |
| PAHs | polycyclic aromatic hydrocarbons |
| UFP | ultrafine particles |
| miRNA | micro RNA |
| AhR | aryl hydrocarbon receptor |
| XMEs | xenobiotic metabolizing enzymes |
| VOCs | volatile organic compounds |
| FDA | food and drug administration |
| FeNO | fraction of exhaled nitric oxide |
| CRP | C-reactive protein |
| NO | nitric oxide |
| NK | natural killer cells |
| PPB | parts per billion |
| ROS | reactive oxygen species |
| H2O2 | hydrogen peroxide |
| BER | base excision repair |
| NER | nucleotide excision repair |
| CD28 | cluster of differentiation 28 |
| FEV1 | fraction of expired volume in 1 s |
| FVC | forced vital capacity |
| PEF | peak expiratory flow |
| OS | impulse oscillometry system |
| PSP | primary spontaneous pneumothorax |
| AHR | airway hyperresponsiveness |